Home>
US Stocks>
Aptose Biosciences Inc

Aptose Biosciences Inc share price today

(APTO)

Aptose Biosciences Inc share price is $0.19 & ₹16.10 as on 5 Dec 2024, 2.30 'hrs' IST

$0.19

Market is closed - opens 8 PM, 05 Dec 2024

View live Aptose Biosciences Inc share price in Dollar and Rupees. Guide to invest in Aptose Biosciences Inc from India. Also see the sentimental analysis on Indian investors investing in Aptose Biosciences Inc. Get details on the Indian mutual funds that are investing in Aptose Biosciences Inc. Get Analyst recommendations and forecasts along with all the Aptose Biosciences Inc's financials.

Aptose Biosciences Inc share price movements

$0.19
$0.20
$0.19
1.74%
Downside
Day's Volatility :6.18%
Upside
4.52%
$0.13
$2.91
$0.19
31.58%
Downside
52 Weeks Volatility :95.53%
Upside
93.47%

Aptose Biosciences Inc Returns

Period	Aptose Biosciences Inc	Index (Russel 2000)
3 Months	-51.37%	0.0%
6 Months	-80.42%	0.0%
1 Year	-92.47%	0.0%
3 Years	-99.4%	-18.1%

Aptose Biosciences Inc Key Statistics

in dollars & INR

Previous Close	$0.1867
Open	$0.1999
Today's High	$0.199
Today's Low	$0.1867
Market Capitalization	$7.2M
Today's Volume	$1.3M
52 Week High	$2.9077
52 Week Low	$0.13
Revenue TTM	$0.0
EBITDA	$-36.2M
Earnings Per Share (EPS)	$-2.75
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-694.13%

How to invest in Aptose Biosciences Inc from India?

It is very easy for Indian residents to invest directly in Aptose Biosciences Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aptose Biosciences Inc stock in both rupees (INR) and dollars (USD). Search for Aptose Biosciences Inc or APTO on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aptose Biosciences Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aptose Biosciences Inc shares which would translate to 4.459 fractional shares of Aptose Biosciences Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Aptose Biosciences Inc

866.67%

Period: Sep 5, 2024 to Dec 4, 2024. Change in 30 Days versus previous period

Investment in Aptose Biosciences Inc from India has grown in the last 30 days as on Dec 5, 2024. 866.67% more purchase transactions for Aptose Biosciences Inc in the last 30 days versus the previous period.

138%

Period: Sep 5, 2024 to Dec 4, 2024. Change in 30 Days versus previous period

Search volume for Aptose Biosciences Inc on INDmoney from India has grown in the last 30 days as on Dec 5, 2024. 138% more investors are searching Aptose Biosciences Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Aptose Biosciences Inc

Armistice Capital, LLC
8.78%
DRW Securities, LLC
3.04%
Sigma Planning Corp
1.20%
Nantahala Capital Management, LLC
0.79%
Morgan Stanley - Brokerage Accounts
0.31%
Cetera Investment Advisers
0.10%

Analyst Recommendation on Aptose Biosciences Inc

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Aptose Biosciences Inc(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Aptose Biosciences Inc

What analysts predicted

Upside of 3584.21%

Current:

$0.19

Target:

$7.00

Insights on Aptose Biosciences Inc

Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 48.5% return, outperforming this stock by 141.0%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.6% return, outperforming this stock by 147.0%

Aptose Biosciences Inc Technicals Summary

Sell

Neutral

Buy

Aptose Biosciences Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Aptose Biosciences Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aptose Biosciences Inc	-51.91%	-80.42%	-92.47%	-99.4%	-99.65%
Regeneron Pharmaceuticals, Inc.	-8.09%	-23.83%	-8.78%	21.97%	108.5%
Biontech Se	5.61%	15.12%	15.65%	-58.12%	304.14%
Alnylam Pharmaceuticals, Inc.	-4.63%	69.46%	44.56%	42.94%	109.6%
Vertex Pharmaceuticals Incorporated	-6.83%	-4.08%	31.76%	127.12%	112.3%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aptose Biosciences Inc	NA	NA	0.0	-2.62	-6.94	-1.36	NA	-0.36
Regeneron Pharmaceuticals, Inc.	18.55	18.55	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.23	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aptose Biosciences Inc	Buy	$7.2M	-99.65%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$83.0B	108.5%	18.55	33.61%
Biontech Se	Buy	$28.9B	304.14%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	109.6%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$120.6B	112.3%	32.84	-4.51%

About Aptose Biosciences Inc

aptose biosciences is a science-driven biotechnology company advancing first-in-class agents to treat life-threatening cancers, such as acute myeloid leukemia (aml), high-risk myelodysplastic syndromes (mds) and other hematologic malignancies. based on insights into the genetic and epigenetic profiles of certain cancers and patient populations, aptose is building a pipeline of novel oncology therapies directed at dysregulated processes and signaling pathways. aptose is developing targeted medicines for precision treatment of these diseases, based on a patient’s specific gene expression signature. in the treatment of cancer, this strategy is intended to optimize efficacy and quality of life by minimizing the cytotoxic side effects associated with conventional therapies. cg026806 (cg’806) is a highly potent first-in-class pan-flt3/btk inhibitor. this small molecule therapeutic agent, exhibits a picomolar ic50 toward the fms-like tyrosine kinase 3 with the internal tandem duplication (flt

Organization	Aptose Biosciences Inc
Employees	35
CEO	Dr. William G. Rice Ph.D.
Industry	Health Technology

Important FAQs about investing in Aptose Biosciences Inc from India :

What is Aptose Biosciences Inc share price today?

Aptose Biosciences Inc (APTO) share price today is $0.19.

Can Indians buy Aptose Biosciences Inc shares?

Yes, Indians can invest in the Aptose Biosciences Inc (APTO) from India.

With INDmoney, you can buy Aptose Biosciences Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Aptose Biosciences Inc at zero transaction cost.

How can I buy Aptose Biosciences Inc shares from India?

It is very easy to buy Aptose Biosciences Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aptose Biosciences Inc be purchased?

Yes, you can buy fractional shares of Aptose Biosciences Inc with INDmoney app.

What are the documents required to start investing in Aptose Biosciences Inc stocks?

To start investing in Aptose Biosciences Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.